CDTX: Cidara Therapeutics Inc. Stocks News on July 1, 2025

CDTX

MT Newswires

5 days ago

Cidara Therapeutics Closes $402.5 Million Stock Offering

Cidara Announces Closing of Upsized Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

CDTX

GlobeNewswire

5 days ago

Cidara Announces Closing of Upsized Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

CDTX

MT Newswires

6 days ago

Cidara Therapeutics Prices $350 Million Public Offering

Cidara Announces Pricing of Upsized Public Offering of Common Stock

CDTX

GlobeNewswire

7 days ago

Cidara Announces Pricing of Upsized Public Offering of Common Stock

CDTX

MT Newswires

7 days ago

Cidara Therapeutics Flu Drug Seen as 'Potentially Transforming the Space', RBC Says

CDTX

MT Newswires

7 days ago

RBC Boosts Price Target on Cidara Therapeutics to $75 From $35, Keeps Outperform, Speculative Risk

CDTX

MT Newswires

8 days ago

Cidara Therapeutics Plans $250 Million Shares Offering

Cidara Therapeutics Doubles As A Universal Flu Shot Becomes A Closer Reality

CDTX

Investor's Business Daily

8 days ago

Cidara Therapeutics Doubles As A Universal Flu Shot Becomes A Closer Reality

Cidara Announces Proposed Public Offering of Common Stock

CDTX

GlobeNewswire

8 days ago

Cidara Announces Proposed Public Offering of Common Stock

CDTX

MT Newswires

8 days ago

Top Midday Gainers

CDTX

MT Newswires

8 days ago

Sector Update: Health Care Stocks Flat to Lower Premarket Monday

CDTX

MT Newswires

8 days ago

Cidara Says Influenza Prevention Drug Meets Primary, Secondary Endpoints; Shares Jump Pre-Bell

CDTX

MT Newswires

8 days ago

Top Premarket Gainers

Cidara Therapeutics Announces Positive Topline Results from its Phase 2b NAVIGATE Trial Evaluating CD388, a Non-Vaccine Preventative of Seasonal Influenza

CDTX

GlobeNewswire

8 days ago

Cidara Therapeutics Announces Positive Topline Results from its Phase 2b NAVIGATE Trial Evaluating CD388, a Non-Vaccine Preventative of Seasonal Influenza

CDTX

MT Newswires

a month ago

RBC Raises Price Target on Cidara Therapeutics to $35 From $31, Keeps Outperform, Speculative Risk

Cidara Therapeutics to Host Virtual R&D Day to Discuss CD388 as a Potential Universal, Once-Per-Flu Season Preventative of Seasonal and Pandemic Influenza on May 22, 2025

CDTX

GlobeNewswire

2 months ago

Cidara Therapeutics to Host Virtual R&D Day to Discuss CD388 as a Potential Universal, Once-Per-Flu Season Preventative of Seasonal and Pandemic Influenza on May 22, 2025

Cidara Therapeutics to Participate in Two Upcoming Investor Conferences

CDTX

GlobeNewswire

2 months ago

Cidara Therapeutics to Participate in Two Upcoming Investor Conferences

CDTX

MT Newswires

2 months ago

RBC Cuts Price Target on Cidara Therapeutics to $31 From $34, Keeps Outperform, Speculative Risk

CDTX

GuruFocus.com

2 months ago

Cidara Therapeutics Inc (CDTX) Q1 2025 Earnings Call Highlights: Promising Advances in ...

CDTX

Associated Press Finance

2 months ago

Cidara Therapeutics: Q1 Earnings Snapshot

Cidara Therapeutics Provides Corporate Update and Reports First Quarter 2025 Financial Results

CDTX

GlobeNewswire

2 months ago

Cidara Therapeutics Provides Corporate Update and Reports First Quarter 2025 Financial Results

CDTX

MT Newswires

2 months ago

Cidara Therapeutics Names Nicole Davarpanah as Chief Medical Officer

Cidara Therapeutics Announces Promotion of Nicole Davarpanah to Chief Medical Officer and Corrina Pavetto to SVP, Clinical Development

CDTX

GlobeNewswire

2 months ago

Cidara Therapeutics Announces Promotion of Nicole Davarpanah to Chief Medical Officer and Corrina Pavetto to SVP, Clinical Development

CDTX

Zacks

2 months ago

Are You Looking for a Top Momentum Pick? Why Cidara Therapeutics (CDTX) is a Great Choice

Cidara Therapeutics to Participate in The Citizens Life Sciences Conference

CDTX

GlobeNewswire

2 months ago

Cidara Therapeutics to Participate in The Citizens Life Sciences Conference

Cidara Therapeutics to Report First Quarter 2025 Financial Results and Host Inaugural Quarterly Conference Call on May 8, 2025

CDTX

GlobeNewswire

2 months ago

Cidara Therapeutics to Report First Quarter 2025 Financial Results and Host Inaugural Quarterly Conference Call on May 8, 2025

Phathom Pharmaceuticals Appoints Ted Schroeder to its Board of Directors

CDTX

GlobeNewswire

3 months ago

Phathom Pharmaceuticals Appoints Ted Schroeder to its Board of Directors

Cidara Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

CDTX

GlobeNewswire

3 months ago

Cidara Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

Cidara Therapeutics to Participate in the 24th Annual Needham Virtual Healthcare Conference

CDTX

GlobeNewswire

3 months ago

Cidara Therapeutics to Participate in the 24th Annual Needham Virtual Healthcare Conference

CDTX

Zacks

3 months ago

Wall Street Analysts Predict a 64.5% Upside in Cidara Therapeutics (CDTX): Here's What You Should Know

Cidara Therapeutics to present on CD388 at ICAR 2025

CDTX

TipRanks

3 months ago

Cidara Therapeutics to present on CD388 at ICAR 2025

Cidara Therapeutics to Participate in World Health Organization Meeting on H5N1 Influenza Preparedness and Response

CDTX

GlobeNewswire

3 months ago

Cidara Therapeutics to Participate in World Health Organization Meeting on H5N1 Influenza Preparedness and Response

Cidara Therapeutics Announces Two Presentations on CD388 in Influenza at International Conference on Antiviral Research (ICAR) 2025

CDTX

GlobeNewswire

3 months ago

Cidara Therapeutics Announces Two Presentations on CD388 in Influenza at International Conference on Antiviral Research (ICAR) 2025

Cidara Therapeutics Announces Publication of CD388 Preclinical Data in Nature Microbiology

CDTX

GlobeNewswire

3 months ago

Cidara Therapeutics Announces Publication of CD388 Preclinical Data in Nature Microbiology

CDTX

Associated Press Finance

4 months ago

Cidara Therapeutics: Q4 Earnings Snapshot

Cidara Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2024 Financial Results

CDTX

GlobeNewswire

4 months ago

Cidara Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2024 Financial Results

Cidara Therapeutics Announces Appointment of Frank Karbe as Chief Financial Officer

CDTX

GlobeNewswire

4 months ago

Cidara Therapeutics Announces Appointment of Frank Karbe as Chief Financial Officer

Cidara Therapeutics to Participate in the Guggenheim Securities SMID Cap Biotech Conference

CDTX

GlobeNewswire

5 months ago

Cidara Therapeutics to Participate in the Guggenheim Securities SMID Cap Biotech Conference

CDTX

Insider Monkey

6 months ago

Here’s Why Cidara Therapeutics, Inc. (CDTX) Is Skyrocketing

CDTX

MT Newswires

6 months ago

Cidara Therapeutics Files Secondary Stock Sale Statement

CDTX

MT Newswires

7 months ago

RBC Initiates Cidara Therapeutics at Outperform, Speculative Risk, With $34 Price Target

Cidara achieves full enrolment in influenza prevention trial

CDTX

Clinical Trials Arena

7 months ago

Cidara achieves full enrolment in influenza prevention trial

Cidara Therapeutics Completes Enrollment of Phase 2b NAVIGATE Trial Evaluating CD388 for Prevention of Seasonal Influenza

CDTX

GlobeNewswire

7 months ago

Cidara Therapeutics Completes Enrollment of Phase 2b NAVIGATE Trial Evaluating CD388 for Prevention of Seasonal Influenza

CDTX

Zacks

7 months ago

Cidara Therapeutics (CDTX) Just Flashed Golden Cross Signal: Do You Buy?

CDTX

MT Newswires

7 months ago

Cidara Therapeutics Expects to Raise $105 Million From Private Placement

Cidara Therapeutics Announces $105 Million Private Placement

CDTX

GlobeNewswire

7 months ago

Cidara Therapeutics Announces $105 Million Private Placement

Cidara Therapeutics to Participate in Evercore 7th Annual HealthCONx Conference

CDTX

GlobeNewswire

7 months ago

Cidara Therapeutics to Participate in Evercore 7th Annual HealthCONx Conference

CDTX

Associated Press Finance

8 months ago

Cidara Therapeutics: Q3 Earnings Snapshot

Cidara Therapeutics to Participate in Two Upcoming November Investor Conferences

CDTX

GlobeNewswire

8 months ago

Cidara Therapeutics to Participate in Two Upcoming November Investor Conferences

Cidara Therapeutics Announces Two Presentations on Drug-Fc Conjugate, CD388, at IDWeek 2024

CDTX

GlobeNewswire

9 months ago

Cidara Therapeutics Announces Two Presentations on Drug-Fc Conjugate, CD388, at IDWeek 2024

CDTX

GlobeNewswire

9 months ago

Cidara Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

Cidara Therapeutics Announces Two Presentations on Innovative Drug-Fc Conjugate, CD388, at the 2024 OPTIONS XII for the Control of Influenza Conference

CDTX

GlobeNewswire

9 months ago

Cidara Therapeutics Announces Two Presentations on Innovative Drug-Fc Conjugate, CD388, at the 2024 OPTIONS XII for the Control of Influenza Conference

Cidara Therapeutics Announces First Subjects Dosed in Phase 2b NAVIGATE Trial Evaluating CD388 for the Prevention of Seasonal Influenza

CDTX

GlobeNewswire

9 months ago

Cidara Therapeutics Announces First Subjects Dosed in Phase 2b NAVIGATE Trial Evaluating CD388 for the Prevention of Seasonal Influenza

Cidara Therapeutics Strengthens its Scientific Advisory Board with Infectious Disease Experts

CDTX

GlobeNewswire

9 months ago

Cidara Therapeutics Strengthens its Scientific Advisory Board with Infectious Disease Experts

Cidara axes 30% of staff to focus on flu prevention drug

CDTX

Pharmaceutical Technology

10 months ago

Cidara axes 30% of staff to focus on flu prevention drug

CDTX

MT Newswires

10 months ago

Cidara Therapeutics to Cut 30% Workforce; Shares Down After-Hours

Cidara Therapeutics Restructures Workforce to Focus on Planned Clinical Development of CD388

CDTX

GlobeNewswire

10 months ago

Cidara Therapeutics Restructures Workforce to Focus on Planned Clinical Development of CD388

Cidara to Present at the H.C. Wainwright 26th Annual Global Investment Conference

CDTX

GlobeNewswire

10 months ago

Cidara to Present at the H.C. Wainwright 26th Annual Global Investment Conference

CDTX

MT Newswires

10 months ago

Cidara Therapeutics Names Jim Beitel as Chief Business Officer

Cidara Therapeutics Announces Appointment of Jim Beitel as Chief Business Officer

CDTX

GlobeNewswire

10 months ago

Cidara Therapeutics Announces Appointment of Jim Beitel as Chief Business Officer

CDTX

Associated Press Finance

a year ago

Cidara Therapeutics: Q2 Earnings Snapshot

Cidara Therapeutics Provides Corporate Update and Reports Second Quarter 2024 Financial Results

CDTX

GlobeNewswire

a year ago

Cidara Therapeutics Provides Corporate Update and Reports Second Quarter 2024 Financial Results

CDTX

GlobeNewswire

a year ago

Cidara Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Cidara Therapeutics to Present Preclinical Data on CD388 at ASM Microbe 2024 Conference

CDTX

GlobeNewswire

a year ago

Cidara Therapeutics to Present Preclinical Data on CD388 at ASM Microbe 2024 Conference

CDTX

Associated Press Finance

a year ago

Cidara Therapeutics: Q1 Earnings Snapshot

Cidara Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results

CDTX

GlobeNewswire

a year ago

Cidara Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results

Cidara Therapeutics Regains Compliance with Nasdaq Continued Listing Rules

CDTX

GlobeNewswire

a year ago

Cidara Therapeutics Regains Compliance with Nasdaq Continued Listing Rules

Cidara Therapeutics Announces Presentations Highlighting Phase 1 and Phase 2a Clinical Data on CD388 at ESCMID 2024

CDTX

GlobeNewswire

a year ago

Cidara Therapeutics Announces Presentations Highlighting Phase 1 and Phase 2a Clinical Data on CD388 at ESCMID 2024

Cidara buys back rights to flu therapy from J&J for $85m

CDTX

Pharmaceutical Technology

a year ago

Cidara buys back rights to flu therapy from J&J for $85m

CDTX

MT Newswires

a year ago

Top Premarket Gainers

Cidara Therapeutics Reacquires Global Development and Commercial Rights to CD388 and Announces Private Placement Financing of $240 Million

CDTX

GlobeNewswire

a year ago

Cidara Therapeutics Reacquires Global Development and Commercial Rights to CD388 and Announces Private Placement Financing of $240 Million

Cidara Therapeutics Announces Divestiture of Rezafungin to Mundipharma* to Focus on Advancing the Clinical Development of Cloudbreak DFC Pipeline

CDTX

GlobeNewswire

a year ago

Cidara Therapeutics Announces Divestiture of Rezafungin to Mundipharma* to Focus on Advancing the Clinical Development of Cloudbreak DFC Pipeline

CDTX

MT Newswires

a year ago

Cidara Therapeutics Q4 Loss Narrows as Sales Rise; Shares Surge Premarket

Cidara Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results

CDTX

GlobeNewswire

a year ago

Cidara Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results

Cidara Therapeutics Announces Receipt of Nasdaq Delinquency Notice

CDTX

GlobeNewswire

a year ago

Cidara Therapeutics Announces Receipt of Nasdaq Delinquency Notice

Cidara Therapeutics Announces Reverse Stock Split

CDTX

GlobeNewswire

a year ago

Cidara Therapeutics Announces Reverse Stock Split

Cidara Therapeutics Presents Promising New Data on Novel Drug-Fc Conjugate Candidates at the American Association for Cancer Research (AACR) Annual Meeting 2024

CDTX

GlobeNewswire

a year ago

Cidara Therapeutics Presents Promising New Data on Novel Drug-Fc Conjugate Candidates at the American Association for Cancer Research (AACR) Annual Meeting 2024

Cidara Therapeutics to Present Preclincal Data on Multiple Novel Drug-Fc Conjugate Candidates at American Association dor Cancer Research (AACR) Annual Meeting 2024

CDTX

GlobeNewswire

a year ago

Cidara Therapeutics to Present Preclincal Data on Multiple Novel Drug-Fc Conjugate Candidates at American Association dor Cancer Research (AACR) Annual Meeting 2024

Steven Cohen's Point72 Adds Cidara Therapeutics to Its Portfolio

CDTX

GuruFocus.com

a year ago

Steven Cohen's Point72 Adds Cidara Therapeutics to Its Portfolio

Cidara Therapeutics Receives $11.14 Million Milestone Payment Following European Approval of REZZAYO

CDTX

GlobeNewswire

a year ago

Cidara Therapeutics Receives $11.14 Million Milestone Payment Following European Approval of REZZAYO

Here's Why Burning Rock Biotech (NASDAQ:BNR) Must Use Its Cash Wisely

CDTX

Simply Wall St.

a year ago

Here's Why Burning Rock Biotech (NASDAQ:BNR) Must Use Its Cash Wisely

Do CB Financial Services' (NASDAQ:CBFV) Earnings Warrant Your Attention?

CDTX

Simply Wall St.

a year ago

Do CB Financial Services' (NASDAQ:CBFV) Earnings Warrant Your Attention?

Are Investors Undervaluing The Container Store Group, Inc. (NYSE:TCS) By 50%?

CDTX

Simply Wall St.

a year ago

Are Investors Undervaluing The Container Store Group, Inc. (NYSE:TCS) By 50%?

CDTX

Associated Press Finance

a year ago

CB Financial Services: Q4 Earnings Snapshot

CDTX

Business Wire

a year ago

CB Financial Services, Inc. Announces Fourth Quarter and Full Year 2023 Financial Results and Declares Quarterly Cash Dividend

CDTX

GlobeNewswire

a year ago

Finward Bancorp Announces Earnings For the Twelve Months and Quarter Ended December 31, 2023

Kopin Receives $1.4 Million Production Order For Specialized Weapon Sight Module

CDTX

Business Wire

a year ago

Kopin Receives $1.4 Million Production Order For Specialized Weapon Sight Module

Cidara Therapeutics Announces Approval of REZZAYO by the MHRA for the Treatment of Invasive Candidiasis in Adults

CDTX

GlobeNewswire

a year ago

Cidara Therapeutics Announces Approval of REZZAYO by the MHRA for the Treatment of Invasive Candidiasis in Adults

OP Bancorp Full Year 2023 Earnings: EPS Misses Expectations

CDTX

Simply Wall St.

a year ago

OP Bancorp Full Year 2023 Earnings: EPS Misses Expectations

Meridian Corporation Reports Fourth Quarter 2023 Results and Announces a Quarterly Dividend of $0.125 per Common Share

CDTX

GlobeNewswire

a year ago

Meridian Corporation Reports Fourth Quarter 2023 Results and Announces a Quarterly Dividend of $0.125 per Common Share

CDTX

Associated Press Finance

a year ago

Chemung Financial: Q4 Earnings Snapshot

Chemung Financial Corp (CHMG) Announces Annual and Q4 Earnings: A Mixed Financial Performance ...

CDTX

GuruFocus.com

a year ago

Chemung Financial Corp (CHMG) Announces Annual and Q4 Earnings: A Mixed Financial Performance ...

Lisata (LSTA) Stock Up More Than 35% in 3 Months: Here's Why

CDTX

Zacks

a year ago

Lisata (LSTA) Stock Up More Than 35% in 3 Months: Here's Why

MetroCity Bankshares (NASDAQ:MCBS) Is Increasing Its Dividend To $0.20

CDTX

Simply Wall St.

a year ago

MetroCity Bankshares (NASDAQ:MCBS) Is Increasing Its Dividend To $0.20

CDTX

Business Wire

a year ago

Coya Therapeutics to Participate in Upcoming Chardan Biotech Leadership Call Series

Is Flexsteel Industries (FLXS) Stock Outpacing Its Consumer Discretionary Peers This Year?

CDTX

Zacks

a year ago

Is Flexsteel Industries (FLXS) Stock Outpacing Its Consumer Discretionary Peers This Year?

i-80 Gold Announces High-Grade Results from Hilltop Drilling at Ruby Hill

CDTX

PR Newswire

a year ago

i-80 Gold Announces High-Grade Results from Hilltop Drilling at Ruby Hill

CDTX

Business Wire

a year ago

Coya Therapeutics Announces Pipeline Expansion of COYA 302 to Include Frontotemporal Dementia and Parkinson’s Disease in Addition to Amyotrophic Lateral Sclerosis

DISCO Pharmaceuticals launches as the surfaceome company with EUR 20 Million in Seed Financing

CDTX

PR Newswire

a year ago

DISCO Pharmaceuticals launches as the surfaceome company with EUR 20 Million in Seed Financing

Twin Disc, Incorporated's (NASDAQ:TWIN) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?

CDTX

Simply Wall St.

a year ago

Latest Cidara Therapeutics Inc. (CDTX) News on July 1, 2025

Share on Social Networks: